1. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions.;Dhruva;Arch Intern Med,2008
2. Social Security Administration. Compilation of the Social Security Laws. Accessed August 17, 2022. https://www.ssa.gov/OP_Home/ssact/title18/1861.htm
3. Federal Register. Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary.” Accessed October 3, 2022. https://www.federalregister.gov/documents/2021/01/14/2021-00707/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and
4. US Food and Drug Administration. Breakthrough Devices Program. Accessed September 14, 2022. https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program
5. Federal Register. Rules and regulations. Accessed October 3, 2022. https://www.federalregister.gov/documents/2021/11/15/2021-24916/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and